Jul 7, 2020 · The EVO Viva ICL is designed for the correction/reduction of up to -20 diopters (D) of nearsightedness with or without presbyopia for patients who are 21 to 60 years of age; and for patients 21 years of age or older who have been treated with an intraocular lens.

The EVO Viva ICL is designed for the correction/reduction of up to -20 diopters (D) of nearsightedness with or without presbyopia for patients who are 21 to 60 years of age and for patients 21 years of age or older who have been treated with an intraocular lens.

5 days ago · STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian ® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries.

EVO Viva™ Implantable Collamer ® Lens (ICL) with Aspheric (EDOF) Optic DIRECTIONS FOR USE PRODUCT INFORMATION Please review this product information completely before performing your initial clinical procedure. All physicians must complete the STAAR Surgical EVO Viva Physician Certification Program; special attention is placed on sizing

The ICL EDOF represents a new treatment option for young myopic people aged 40-50 years (with -1.0 to -18.0 Dpt without astigmatism) who suffer from presbyopia and who complain about reading glasses or progressive glasses.

The innovative EVO Viva lens adds near and intermediate vision correction for patients with presbyopia. Patient Selection Indications . As approved by the US FDA, the Visian ICL is indicated for adults 21-45 years of age

Purpose: To assess the clinical and aberrometric outcomes of a new Implantable Collamer Lens (EVO Viva ICL; STAAR Surgical) to correct moderate to high myopia and presbyopia. Methods: The study included 80 eyes of 40 patients who had bilateral EVO Viva ICL implantation.

Mar 5, 2025 · The EVO Viva ICL is designed for the correction/reduction of up to -20 diopters (D) of nearsightedness with or without presbyopia for patients who are 21 to 60 years of age; and for patients 21 years of age or older who have been treated with an intraocular lens.

The EVO Viva ICL is designed to provide a wide range of clear vision through its extended depth of focus (EDOF) technology. This lens offers multiple focal points, enabling it to correct various vision issues such as nearsightedness (myopia) and age-related near vision loss (presbyopia).

Feb 27, 2025 · STAAR Surgical announced that its EVO Viva presbyopia correcting implantable collamer lens (ICL) has been approved for sale. STAAR received CE Mark approval of the presbyopic indication for its EVO+ Visian ICL with Aspheric (EDOF) Optic, commercially marketed as “EVO Viva,” from its European Notified Body, DEKRA, on July 2, 2020.